David L. Grange's most recent trade in Tonix Pharmaceuticals Holding Corp was a trade of 10,000 Stock Option done . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding | David L. Grange | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 10,000 | 10,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Holding | David L. Grange | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 104,621 | 104,621 | - | - | Stock Option | |
| Tonix Pharmaceuticals Holding | David L. Grange | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2023 | 60,000 | 60,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Holding | David L. Grange | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 270,882 | 270,882 | - | - | Stock Option |